Therapeutics play an important role in all stages of COVID-19 disease: to prevent infection; suppress symptoms and spread of infection to others; treat or prevent symptoms; as a life-saving treatment for severe symptoms; and as a treatment that can speed up recovery. The Therapeutics Pillar supports access to safe and effective therapeutics of assured quality to save lives from COVID-19 and to minimise its global health and economic threat. The therapeutics pillar is led by Unitaid and Wellcome.
There are currently 3 workstreams within the Therapeutics pillar: Rapid evidence assessment of candidates, market preparedness and adequate deployment in all countries. Each working group has 2 reserved spaces (6 in total) for civil society and communities. The participation and representation of civil society and communities on this pillar is coordinated by Dr Enow Stevens based in Cameroon.
For further information, or any questions, please contact: courtenay@stopaids.org.uk
